Synopsis of recent research by authors named "Adam Amoss"
Adam Amoss's research primarily focuses on drug discovery methodologies, particularly through the development and application of advanced screening techniques in identifying bioactive compounds.
A significant aspect of his work involves improving virtual screening processes to enhance the efficiency of high-throughput screening (HTS) by employing novel heuristics and mass spectrometry to reduce false positives.
His studies also explore specific therapeutic targets, such as NMDA receptors, identifying selective inhibitors that may have implications for treating cognitive impairments associated with disorders like schizophrenia and Alzheimer's disease.
